Evommune, Inc.

EVMN ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $76.1M

Liabilities Breakdown FY2024

Total Liabilities: $28.5M